RILUZOLE

Quinn Pharmaceuticals🇺🇸 United States

FDA Page

Effective Date: Apr 24, 2026
Approval ID: ccead445-970c-46a1-9532-2848cc2aa3b6
Products: 1 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RILUZOLE TABLETS safely and effectively. See full prescribing information for RILUZOLE TABLETS. RILUZOLE tablets, for oral use Initial U.S. Approval: 1995

Quick Stats

Total Products1

Labelers3

Label Sections33

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.